Author response for 'Inhibition of fatty acid synthase with <scp>FT</scp> ‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with <scp>NAFLD</scp> non‐alcoholic fatty liver disease: results from two early phase randomized trials'

Authors :: null Carine Beysen
null Patricia Schroeder
null Eric Wu
null Julie Brevard
null Maria Ribadeneira
null Wei Lu
null Kiran Dole
null Terry E O’Reilly
null Linda Morrow
null Marcus Hompesch
null Marc K Hellerstein
null Kelvin Li
null Lars Johansson
null Patrick F Kelly
Publication Year :: 2020
Publisher :: Wiley, 2020.

Full Text Access

Tools